1. Home
  2. ELVN vs VBTX Comparison

ELVN vs VBTX Comparison

Compare ELVN & VBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELVN
  • VBTX
  • Stock Information
  • Founded
  • ELVN 2016
  • VBTX 2009
  • Country
  • ELVN United States
  • VBTX United States
  • Employees
  • ELVN N/A
  • VBTX N/A
  • Industry
  • ELVN Biotechnology: Pharmaceutical Preparations
  • VBTX Major Banks
  • Sector
  • ELVN Health Care
  • VBTX Finance
  • Exchange
  • ELVN Nasdaq
  • VBTX Nasdaq
  • Market Cap
  • ELVN 1.2B
  • VBTX 1.3B
  • IPO Year
  • ELVN 2020
  • VBTX 2014
  • Fundamental
  • Price
  • ELVN $20.73
  • VBTX $27.62
  • Analyst Decision
  • ELVN Strong Buy
  • VBTX Buy
  • Analyst Count
  • ELVN 5
  • VBTX 6
  • Target Price
  • ELVN $41.20
  • VBTX $30.00
  • AVG Volume (30 Days)
  • ELVN 747.2K
  • VBTX 376.1K
  • Earning Date
  • ELVN 08-12-2025
  • VBTX 07-22-2025
  • Dividend Yield
  • ELVN N/A
  • VBTX 3.19%
  • EPS Growth
  • ELVN N/A
  • VBTX 18.60
  • EPS
  • ELVN N/A
  • VBTX 2.04
  • Revenue
  • ELVN N/A
  • VBTX $416,460,000.00
  • Revenue This Year
  • ELVN N/A
  • VBTX $12.52
  • Revenue Next Year
  • ELVN N/A
  • VBTX $5.50
  • P/E Ratio
  • ELVN N/A
  • VBTX $13.54
  • Revenue Growth
  • ELVN N/A
  • VBTX 14.03
  • 52 Week Low
  • ELVN $13.30
  • VBTX $20.10
  • 52 Week High
  • ELVN $30.03
  • VBTX $31.62
  • Technical
  • Relative Strength Index (RSI)
  • ELVN 52.08
  • VBTX 76.08
  • Support Level
  • ELVN $19.22
  • VBTX $25.72
  • Resistance Level
  • ELVN $21.90
  • VBTX $25.70
  • Average True Range (ATR)
  • ELVN 1.49
  • VBTX 0.63
  • MACD
  • ELVN -0.19
  • VBTX 0.27
  • Stochastic Oscillator
  • ELVN 39.43
  • VBTX 91.65

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

About VBTX Veritex Holdings Inc.

Veritex Holdings Inc is engaged in the provision of commercial banking products and services to small to medium-sized businesses and professionals. The bank provides a range of banking services to individual and corporate customers, which include commercial and retail lending, and the acceptance of checking and savings deposits. It offers a suite of online banking solutions, including access to account balances, online transfers, online bill payment and electronic delivery of customer statements, as well as automated teller machines, and banking by telephone, mail and personal appointment. The company's primary sources of revenue are derived from interest and dividends earned on loans, debt and equity securities and other financial instruments.

Share on Social Networks: